Obstetrics and Gynecology

Medicine & Life Sciences

1. Acute Lung Injury 20%
2. Amniotic Fluid 18%
3. Apoptosis 14%
4. Atypical Squamous Cells of the Cervix 14%
5. Autoantibodies 30%
6. Autoimmunity 34%
7. Biomarkers 24%
8. Catalase 14%
9. Celiac Disease 16%
10. Cell Biology 14%
11. Cell Proliferation 14%
12. Cervical Intraepithelial Neoplasia 30%
13. Cervix Uteri 25%
14. Child 20%
15. Clinical Trials 17%
16. Clomiphene 18%
17. Colposcopy 47%
18. Complementary DNA 15%
19. Confidence Intervals 17%
20. DNA 18%
21. Early Detection of Cancer 16%
22. Endometriosis 24%
23. Endothelial Cells 23%
24. Endothelin-1 25%
25. Enzymes 16%
26. Estrogen Receptors 14%
27. Estrogens 19%
28. Fertility 30%
29. Fetal Heart Rate 44%
30. Fetal Movement 19%
31. Fetus 21%
32. Follicle Stimulating Hormone 17%
33. Gene Expression 21%
34. Genes 69%
35. Genitalia 16%
36. Genotype 18%
37. Gonadotropin-Releasing Hormone 23%
38. Gonadotropins 19%
39. Human papillomavirus 11 22%
40. Human papillomavirus 6 33%
41. Hypogonadism 40%
42. Hypoxia 26%
43. Hysterectomy 16%
44. Inbred NOD Mouse 19%
45. Incidence 15%
46. Infections 20%
47. Infertility 61%
48. Insemination 13%
49. Insulin 14%
50. Intellectual Disability 18%
51. Kallmann Syndrome 38%
52. Leiomyoma 70%
53. Live Birth 29%
54. Lung 49%
55. Messenger RNA 16%
56. Mothers 33%
57. Mutation 43%
58. N,N-dimethylarginine 14%
59. Neoplasms 33%
60. Nitric Oxide 45%
61. Nitric Oxide Synthase 27%
62. Nitric Oxide Synthase Type I 24%
63. Nitric Oxide Synthase Type III 30%
64. Organism Cloning 17%
65. Ovarian Epithelial Carcinoma 16%
66. Ovarian Neoplasms 39%
67. Ovulation Induction 30%
68. Oxidative Stress 18%
69. Oxidoreductases 14%
70. Papanicolaou Test 38%
71. Papillomavirus Infections 24%
72. Papillomavirus Vaccines 59%
73. Pelvic Organ Prolapse 13%
74. Phenotype 24%
75. Placebos 26%
76. Polycystic Ovary Syndrome 63%
77. Population 26%
78. Pregnancy 66%
79. Pregnancy Outcome 14%
80. Proteins 41%
81. Proteomics 15%
82. Pulmonary Artery 16%
83. Pulmonary Hypertension 44%
84. Randomized Controlled Trials 24%
85. Reactive Oxygen Species 14%
86. Safety 15%
87. Serum 24%
88. Single Nucleotide Polymorphism 19%
89. Smooth Muscle Myocytes 24%
90. Superoxides 19%
91. Survival 16%
92. Testosterone 18%
93. Therapeutics 31%
94. Trophoblasts 15%
95. Type 1 Diabetes Mellitus 100%
96. Uterine Cervical Neoplasms 40%
97. Vaccination 13%
98. Vaccines 29%
99. Virus-Like Particle Vaccines 18%